Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity

• Hajime Kashima,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan

  ⨯
• Fumiyasu Momose,

  Affiliation Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Mie 514-8507, Japan

  ⨯
• Hiroshi Umehara,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan

  ⨯
• Nao Miyoshi,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan

  ⨯
• Naohisa Ogo,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan

  ⨯
• Daisuke Muraoka,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan

  ⨯
• Hiroshi Shiku,

  Affiliation Mie University Center for Comprehensive Cancer Immunotherapy, Mie 514-8507, Japan

  ⨯
• Naozumi Harada ,

  * E-mail: aasai@u-shizuoka-ken.ac.jp (AA); nharada@clin.medic.mie-u.ac.jp (NH)

  Affiliation Mie University Center for Comprehensive Cancer Immunotherapy, Mie 514-8507, Japan

  ⨯
• Akira Asai

  * E-mail: aasai@u-shizuoka-ken.ac.jp (AA); nharada@clin.medic.mie-u.ac.jp (NH)

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan

  ⨯